Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia
This study is currently recruiting participants.
Study NCT00545974 Information provided by University of California, San Francisco
First Received: October 16, 2007 Last Updated: October 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Frontal Lobe Dementia
Frontotemporal Lobe Dementia
Semantic Dementia
Additional conditions recognized in this trial
Aphasia, Primary Progressive
Dementia
Pick Disease of the Brain
More general conditions related to this trial
Aphasia
Brain Diseases
Central Nervous System Diseases
Communication Disorders
Delirium, Dementia, Amnestic, Cognitive Disorders
Language Disorders
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Signs and Symptoms
Speech Disorders
Interventions listed in this trial
memantine
Placebo pill
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Antiparkinson Agents
Central Nervous System Agents
Dopamine Agents
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of California, San Francisco
Forest Laboratories
Back to top of Main Content
